|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
136,480,000 |
Market
Cap: |
3.84(B) |
Last
Volume: |
503,160 |
Avg
Vol: |
501,781 |
52
Week Range: |
$26.23 - $39.94 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Perrigo is a provider of over-the-counter health and wellness solutions that can be self-managed. Co.'s segments are as follows: Consumer Self-Care Americas, which is focused primarily on the sale of self-care products in categories including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements; Consumer Self-Care International, which develops, manufactures, markets, and distributes European consumer self-care brands in the upper respiratory, pain and sleep-aids, digestive health, vitamins, minerals and supplements; and Prescription Pharmaceuticals, which develops, manufactures, and markets a portfolio of generic prescription drugs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Hendrickson John T |
EVP Global Operations & Supply |
|
2011-08-17 |
4 |
OE |
$15.47 |
$84,776 |
D/D |
5,480 |
5,480 |
|
- |
|
Lebel Refael |
EVP & GM Perrigo Israel |
|
2011-08-17 |
4 |
S |
$89.25 |
$456,228 |
D/D |
(5,101) |
0 |
|
- |
|
Lebel Refael |
EVP & GM Perrigo Israel |
|
2011-08-17 |
4 |
OE |
$15.47 |
$61,880 |
D/D |
4,000 |
4,000 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-07-13 |
4 |
AS |
$92.00 |
$133,032 |
D/D |
(1,446) |
4,477 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-07-13 |
4 |
OE |
$14.69 |
$21,242 |
D/D |
1,446 |
5,923 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-07-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
4,477 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-07-06 |
4 |
AS |
$92.00 |
$18,400 |
D/D |
(200) |
5,477 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-07-06 |
4 |
OE |
$14.69 |
$2,938 |
D/D |
200 |
5,677 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-06-21 |
4 |
AS |
$88.00 |
$140,800 |
D/D |
(1,600) |
5,477 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-06-21 |
4 |
OE |
$14.69 |
$23,504 |
D/D |
1,600 |
7,077 |
|
- |
|
Lebel Refael |
EVP & GM Perrigo Israel |
|
2011-06-03 |
4/A |
S |
$84.65 |
$188,346 |
D/D |
(2,225) |
1,101 |
|
- |
|
Lebel Refael |
EVP & GM Perrigo Israel |
|
2011-06-03 |
4 |
S |
$84.65 |
$187,500 |
D/D |
(2,215) |
1,111 |
|
- |
|
Yu Louis |
Senior VP Global Quality |
|
2011-06-03 |
4 |
S |
$85.60 |
$153,738 |
D/D |
(1,796) |
5,490 |
|
- |
|
Yu Louis |
Senior VP Global Quality |
|
2011-06-03 |
4 |
OE |
$30.06 |
$53,988 |
D/D |
1,796 |
7,286 |
|
- |
|
Brlas Laurie |
Director |
|
2011-05-31 |
4 |
S |
$85.11 |
$494,841 |
D/D |
(5,814) |
16,558 |
|
- |
|
Brlas Laurie |
Director |
|
2011-05-31 |
4 |
OE |
$16.77 |
$97,501 |
D/D |
5,814 |
22,372 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-05-26 |
5 |
GD |
$0.00 |
$0 |
I/I |
100 |
1,051,937 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-05-24 |
5 |
GD |
$0.00 |
$0 |
I/I |
473 |
1,052,037 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-05-20 |
5 |
GD |
$0.00 |
$0 |
I/I |
155 |
1,052,510 |
|
- |
|
Arkin Moshe |
Director |
|
2011-05-20 |
4 |
S |
$87.00 |
$34,800 |
I/I |
(400) |
5,233,267 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-05-19 |
4 |
S |
$86.91 |
$173,841 |
D/D |
(2,000) |
5,477 |
|
- |
|
Shah Jatin |
Sr VP & Chief Scientific Offic |
|
2011-05-19 |
4 |
OE |
$14.69 |
$29,380 |
D/D |
2,000 |
7,477 |
|
- |
|
Arkin Moshe |
Director |
|
2011-05-19 |
4 |
S |
$87.04 |
$3,269,003 |
I/I |
(37,557) |
5,233,667 |
|
- |
|
Arkin Moshe |
Director |
|
2011-05-18 |
4 |
S |
$86.31 |
$12,325,885 |
I/I |
(142,805) |
5,271,224 |
|
- |
|
Jandernoa Michael J |
Director |
|
2011-05-16 |
5 |
GD |
$0.00 |
$0 |
I/I |
154 |
1,052,665 |
|
- |
|
1400 Records found
|
|
Page 20 of 56 |
|
|